At Stanford we changed to Vanishpoint only for the 1ml syringes (including the insulin syringe). We did actualize a 40% decrease in injuries on the floors associated with this size syringe.  We found that activating the safety on the 1 ml BD syringe put the users finger right at the point of the needle.  Instructions are that you are supposed to visualize the safety when activating it on the BD, but our observations were that clinicians were activating the safety while not looking. This resulting in injuries occurring with safety activation.  We have kept BD as our vendor for all other syringes. They do have a retractable syringe option in sizes other than the 1 ml.

Hope this is helpful.

Mary

Take 3 minutes to watch this doodle on sharps safety.  https://www.youtube.com/watch?v=mpm_7pNn5GM&feature=youtu.be

Mary Spangler, M.S., N.P., COHN-S

Administrative Director, Occupational Health Services

Stanford Health Care & Stanford Children’s Health Care

300 Pasteur Drive, M/C 5205, Stanford, CA 94305-5513

Office: (650) 725-9583 Fax: (650) 498-7748 (fax)

mspangler@stanfordhealthcare.org

Administrative Assistant Michelle Fitch 650-725-2529   mfitch@stanfordhealthcare.org

Confidential Information: This communication and any attachments may contain confidential or privileged information for the use by the designated recipient(s) named above. If you are not the intended recipient, you are hereby notified that you have received this communication in error and that any review, disclosure, dissemination, distribution or copying of it or the attachments is strictly prohibited. If you have received this communication in error, please contact me and destroy all copies of the communication and attachments. Thank you.

From: MCOH-EH [mailto:mcoh-eh-bounces+mspangler=stanfordhealthcare.org@mylist.net] On Behalf Of Hudson, T. Warner
Sent: Wednesday, February 22, 2017 1:59 PM
To: MCOH/EH <mcoh-eh@mylist.net>
Subject: Re: [MCOH-EH] Vanish Point needle/syringe sets

We have not; use the BD retractable butterflies…could not get the Vanish Point in the UC wide contracts we have with Novation.

Warner

T. Warner Hudson, MD FACOEM, FAAFP

Medical Director, Occupational and Employee Health

UCLA Health System and Campus

Office 310.825.9146

Fax 310.206.4585

Pager 800.233.7231  ID 27132

E-mail twhudson@mednet.ucla.edu

Website www.ohs.uclahealth.org

From: MCOH-EH [mailto:mcoh-eh-bounces+twhudson=mednet.ucla.edu@mylist.net] On Behalf Of Galaid Edward I
Sent: Thursday, February 02, 2017 8:49 AM
To: mcoh-eh@mylist.net
Subject: [MCOH-EH] Vanish Point needle/syringe sets

We took a look at the Vanish Point needle/syringe sets yesterday.  Seems to be a promising way to reduce needlesticks.  Nurse mgrs who looked at them liked them, except for their IV setup.

Most of their products involve a springloaded retractor or other mechanism that pulls the needle back into the barrel of the syringe.  They have many sizes, including insulin and tuberculin.

Sales rep said that hospitals that have used their products have had substantial reductions in their BBFEs.

He dropped a bunch of names of health systems currently using the Vanish Point products but wondering if anyone who is on the List has had any experience with them.

Thanks

Ed Galaid

Edward I. Galaid, MD, MPH
ABIM, ABPM (Occ Med, PH&GPM)

Medical Director, Occupational Health Partners

Roper St. Francis Healthcare   Charleston, SC

Member, ACOEM Task Group on Medical Guidance for Law Enforcement Officers

843-906-0519

---

Our Mission: Healing all people with compassion, faith and excellence.

Confidentiality Notice: This e-mail message, including
any attachments, is for the sole use of the intended
recipients and may contain confidential and/or legally
privileged information. If you are not the intended
recipient, please contact the sender by reply e-mail and
destroy all copies of the original message. Any
unauthorized review, use, disclosure, or distribution is
prohibited. Thank you.

---

UCLA HEALTH SCIENCES IMPORTANT WARNING: This email (and any attachments) is only intended for the use of the person or entity to which it is addressed, and may contain information that is privileged and confidential. You, the recipient, are obligated to maintain it in a safe, secure and confidential manner. Unauthorized redisclosure or failure to maintain confidentiality may subject you to federal and state penalties. If you are not the intended recipient, please immediately notify us by return email, and delete this message from your computer.